Alembic Pharmaceuticals Limited.
Healthcare · Pharmaceuticals
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
- Market cap
- ₹16,518 cr
- P/E (TTM)
- 24.1
- P/B (latest)
- 2.9
- ROE (TTM)
- 11.9%
- ROCE (TTM)
- 14.5%
- Sales CAGR 3y
- 9.1%
- PAT CAGR 3y
- 25.4%
- Debt / equity
- 0.24x
- Promoter
- 69.9%
- Dividend yield
- 1.43%
- Size
- Micro
- Codes
- APLLTD · 533573
₹861.5 · 29 Sept 2026
52-week ₹646.55 – ₹960.7 · ADTV ₹11.5 cr · price-only.
Sales and net profit by fiscal year, ₹ crore
Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ